Research Articles
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise A. Brinton, Fiona Bruinsma, Daniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica N. McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo B. Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, Veronica Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Michael Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, for the OPAL Study Group, for the AOCS Group, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle and Tracy A. O'Mara
Dylan M. Glubb
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Deborah J. Thompson
2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Katja K.H. Aben
3Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
4Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Ahmad Alsulimani
5Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Frederic Amant
6Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
Daniela Annibali
6Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.
John Attia
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
8Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
Aurelio Barricarte
9CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
10Navarra Public Health Institute, Pamplona, Spain.
11Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Matthias W. Beckmann
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Andrew Berchuck
13Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina.
Marina Bermisheva
14Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
Marcus Q. Bernardini
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada.
Katharina Bischof
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
Line Bjorge
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
Clara Bodelon
18Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Alison H. Brand
19Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
20University of Sydney, Sydney, New South Wales, Australia.
James D. Brenton
21Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Louise A. Brinton
18Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Fiona Bruinsma
22Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
Daniel D. Buchanan
23Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
24Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
25Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
26University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
Stefanie Burghaus
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Ralf Butzow
27Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Hui Cai
28Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Michael E. Carney
29John A. Burns School of Medicine, Department of Obstetrics and Gynecology, University of Hawaii, Honolulu, Hawaii.
Stephen J. Chanock
30Division of Cancer Epidemiology and Genetics, NCI, NIH, Department of Health and Human Services, Bethesda, Maryland.
Chu Chen
31Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Xiao Qing Chen
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Zhihua Chen
32Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida.
Linda S. Cook
33University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico.
34Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
Julie M. Cunningham
35Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Immaculata De Vivo
36Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Anna deFazio
19Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Jennifer A. Doherty
39Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah.
Thilo Dörk
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Andreas du Bois
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
42Praxis für Humangenetik, Wiesbaden, Germany.
Alison M. Dunning
43Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Matthias Dürst
44Department of Gynaecology, Jena University Hospital- Friedrich Schiller University, Jena, Germany.
Todd Edwards
45Division of Epidemiology, Center for Human Genetics Research, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Robert P. Edwards
46Ovarian Cancer Center of Excellence, Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Arif B. Ekici
48Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Ailith Ewing
2Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Peter A. Fasching
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
49David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California.
Sarah Ferguson
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada.
James M. Flanagan
50Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Florentia Fostira
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research “Demokritos,” Athens, Greece.
George Fountzilas
52Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
Christine M. Friedenreich
34Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada.
Bo Gao
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
53The Crown Princess Mary Cancer Centre Westmead, Sydney-West Cancer Network, Westmead Hospital, Sydney, New South Wales, Australia.
Mia M. Gaudet
54Department of Population Science, American Cancer Society, Atlanta, Georgia.
Jan Gawełko
55Institute of Nursing and Health Sciences, Medical Faculty, University of Rzeszów, Rzeszów, Poland.
Aleksandra Gentry-Maharaj
56MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Graham G. Giles
22Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
24Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
57Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Rosalind Glasspool
58Department of Medical Oncology, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
Marc T. Goodman
59Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, California.
Jacek Gronwald
60Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Holly R. Harris
61Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
62Department of Epidemiology, University of Washington, Seattle, Washington.
Philipp Harter
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
Alexander Hein
12Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Florian Heitz
41Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte (KEM), Essen, Germany.
Michelle A.T. Hildebrandt
63Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Peter Hillemanns
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Estrid Høgdall
64Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
65Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Claus K. Høgdall
66The Juliane Marie Centre, Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Elizabeth G. Holliday
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
8Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
David G. Huntsman
67British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada.
68Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
69Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
70Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada.
Tomasz Huzarski
71Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
72Department of Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland.
Anna Jakubowska
60Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
73Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
Allan Jensen
64Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Michael E. Jones
74Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Beth Y. Karlan
75David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.
Anthony Karnezis
76Department of Pathology and Laboratory Medicine, UC Davis Medical Center, Sacramento, California.
Joseph L. Kelley
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Elza Khusnutdinova
14Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
77Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
Jeffrey L. Killeen
78Department of Pathology, Kapiolani Medical Center for Women and Children, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
Susanne K. Kjaer
64Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
79Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Rüdiger Klapdor
80Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Martin Köbel
81Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
Bozena Konopka
82Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Irene Konstantopoulou
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research “Demokritos,” Athens, Greece.
Reidun K. Kopperud
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
Madhuri Koti
83Departments of Biomedical and Molecular Sciences and Obstetrics and Gynaecology, Cancer Biology and Genetics Division, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
Peter Kraft
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
84Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Jolanta Kupryjanczyk
82Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Diether Lambrechts
85VIB Center for Cancer Biology, Leuven, Belgium.
86Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
Melissa C. Larson
87Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Loic Le Marchand
88Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Shashikant Lele
89Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Jenny Lester
75David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, California.
Andrew J. Li
90Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Dong Liang
91College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas.
Clemens Liebrich
92Clinics of Gynaecology, Cancer Center Wolfsburg, Wolfsburg, Germany.
Loren Lipworth
93Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Jolanta Lissowska
94Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center, Oncology Institute, Warsaw, Poland.
Lingeng Lu
95Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
Karen H. Lu
96Department of Gynecologic Oncology and Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
Alessandra Macciotta
97Evangelische Kliniken Essen-Mitte Klinik für Gynäkologie und gynäkologische Onkologie, Essen, Germany.
Amalia Mattiello
98Dipertimento Di Medicina Clinca e Chirurgia, Federico II University, Naples, Italy.
Taymaa May
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada.
Jessica N. McAlpine
99British Columbia's Ovarian Cancer Research (OVCARE) Program–Gynecologic Tissue Bank, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver General Hospital and BC Cancer, Vancouver, BC, Canada.
Valerie McGuire
100Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
Iain A. McNeish
101Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery and Cancer, Imperial College London, London, UK.
102Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Usha Menon
56MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
Francesmary Modugno
47Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
103Womens Cancer Research Center, Magee-Women's Research Institute and Hillman Cancer Center, Pittsburgh, Pennsylvania.
Kirsten B. Moysich
5Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York.
Heli Nevanlinna
104Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Kunle Odunsi
89Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York.
Håkan Olsson
105Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Sandra Orsulic
90Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Ana Osorio
106Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
107Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Domenico Palli
108Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Tjoung-Won Park-Simon
40Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Celeste L. Pearce
109Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan.
110Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
Tanja Pejovic
111Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon.
112Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
Jennifer B. Permuth
113Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
Agnieszka Podgorska
82Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Susan J. Ramus
114School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, New South Wales, Australia.
115Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
Timothy R. Rebbeck
116Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
117Dana-Farber Cancer Institute, Boston, Massachusetts.
Marjorie J. Riggan
13Department of Gynecologic Oncology, Duke University Hospital, Durham, North Carolina.
Harvey A. Risch
95Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
Joseph H. Rothstein
118Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
119Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Ingo B. Runnebaum
44Department of Gynaecology, Jena University Hospital- Friedrich Schiller University, Jena, Germany.
Rodney J. Scott
7Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia.
120Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia.
121Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.
Thomas A. Sellers
113Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
Janine Senz
67British Columbia's Ovarian Cancer Research (OVCARE) Program, BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada.
68Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Veronica Wendy Setiawan
122Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Nadeem Siddiqui
123Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
Weiva Sieh
118Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
119Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
Beata Spiewankiewicz
124Tytus Chałbiński Specialist Hospital in Radom, Warsaw, Poland.
Rebecca Sutphen
125Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida.
Anthony J. Swerdlow
74Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
126Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Lukasz Michael Szafron
127Department of Immunology, the Maria Sklodowska-Curie Institute–Oncology Center, Warsaw, Poland.
Soo Hwang Teo
128Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
129Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Pamela J. Thompson
59Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, California.
Liv Cecilie Vestrheim Thomsen
16Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
17Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
Linda Titus
130Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Alicia Tone
15Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada.
Rosario Tumino
131Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Berlin, Germany.
Constance Turman
37Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Adriaan Vanderstichele
132Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Digna Velez Edwards
133Division of Quantitative Sciences, Department of Obstetrics and Gynecology, Department of Biomedical Sciences, Women's Health Research, Vanderbilt University Medical Center, Nashville, Tennessee.
Ignace Vergote
132Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Robert A. Vierkant
87Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Zhaoming Wang
18Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Shan Wang-Gohrke
134Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Penelope M. Webb
135Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
135Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
38Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
136Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Emily White
62Department of Epidemiology, University of Washington, Seattle, Washington.
137Fred Hutchinson Cancer Research Center, Seattle, Washington.
Alice S. Whittemore
100Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
138Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California.
Stacey J. Winham
87Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
Xifeng Wu
63Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Anna H. Wu
122Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Drakoulis Yannoukakos
51Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research “Demokritos,” Athens, Greece.
Amanda B. Spurdle
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Tracy A. O'Mara
1Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
DOI: 10.1158/1055-9965.EPI-20-0739 Published January 2021
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
January 2021
Volume 30, Issue 1
Volume 30, Issue 1
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise A. Brinton, Fiona Bruinsma, Daniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica N. McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo B. Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, Veronica Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Michael Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, for the OPAL Study Group, for the AOCS Group, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle and Tracy A. O'Mara
Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 217-228; DOI: 10.1158/1055-9965.EPI-20-0739
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
Dylan M. Glubb, Deborah J. Thompson, Katja K.H. Aben, Ahmad Alsulimani, Frederic Amant, Daniela Annibali, John Attia, Aurelio Barricarte, Matthias W. Beckmann, Andrew Berchuck, Marina Bermisheva, Marcus Q. Bernardini, Katharina Bischof, Line Bjorge, Clara Bodelon, Alison H. Brand, James D. Brenton, Louise A. Brinton, Fiona Bruinsma, Daniel D. Buchanan, Stefanie Burghaus, Ralf Butzow, Hui Cai, Michael E. Carney, Stephen J. Chanock, Chu Chen, Xiao Qing Chen, Zhihua Chen, Linda S. Cook, Julie M. Cunningham, Immaculata De Vivo, Anna deFazio, Jennifer A. Doherty, Thilo Dörk, Andreas du Bois, Alison M. Dunning, Matthias Dürst, Todd Edwards, Robert P. Edwards, Arif B. Ekici, Ailith Ewing, Peter A. Fasching, Sarah Ferguson, James M. Flanagan, Florentia Fostira, George Fountzilas, Christine M. Friedenreich, Bo Gao, Mia M. Gaudet, Jan Gawełko, Aleksandra Gentry-Maharaj, Graham G. Giles, Rosalind Glasspool, Marc T. Goodman, Jacek Gronwald, Holly R. Harris, Philipp Harter, Alexander Hein, Florian Heitz, Michelle A.T. Hildebrandt, Peter Hillemanns, Estrid Høgdall, Claus K. Høgdall, Elizabeth G. Holliday, David G. Huntsman, Tomasz Huzarski, Anna Jakubowska, Allan Jensen, Michael E. Jones, Beth Y. Karlan, Anthony Karnezis, Joseph L. Kelley, Elza Khusnutdinova, Jeffrey L. Killeen, Susanne K. Kjaer, Rüdiger Klapdor, Martin Köbel, Bozena Konopka, Irene Konstantopoulou, Reidun K. Kopperud, Madhuri Koti, Peter Kraft, Jolanta Kupryjanczyk, Diether Lambrechts, Melissa C. Larson, Loic Le Marchand, Shashikant Lele, Jenny Lester, Andrew J. Li, Dong Liang, Clemens Liebrich, Loren Lipworth, Jolanta Lissowska, Lingeng Lu, Karen H. Lu, Alessandra Macciotta, Amalia Mattiello, Taymaa May, Jessica N. McAlpine, Valerie McGuire, Iain A. McNeish, Usha Menon, Francesmary Modugno, Kirsten B. Moysich, Heli Nevanlinna, Kunle Odunsi, Håkan Olsson, Sandra Orsulic, Ana Osorio, Domenico Palli, Tjoung-Won Park-Simon, Celeste L. Pearce, Tanja Pejovic, Jennifer B. Permuth, Agnieszka Podgorska, Susan J. Ramus, Timothy R. Rebbeck, Marjorie J. Riggan, Harvey A. Risch, Joseph H. Rothstein, Ingo B. Runnebaum, Rodney J. Scott, Thomas A. Sellers, Janine Senz, Veronica Wendy Setiawan, Nadeem Siddiqui, Weiva Sieh, Beata Spiewankiewicz, Rebecca Sutphen, Anthony J. Swerdlow, Lukasz Michael Szafron, Soo Hwang Teo, Pamela J. Thompson, Liv Cecilie Vestrheim Thomsen, Linda Titus, Alicia Tone, Rosario Tumino, Constance Turman, Adriaan Vanderstichele, Digna Velez Edwards, Ignace Vergote, Robert A. Vierkant, Zhaoming Wang, Shan Wang-Gohrke, Penelope M. Webb, for the OPAL Study Group, for the AOCS Group, Emily White, Alice S. Whittemore, Stacey J. Winham, Xifeng Wu, Anna H. Wu, Drakoulis Yannoukakos, Amanda B. Spurdle and Tracy A. O'Mara
Cancer Epidemiol Biomarkers Prev January 1 2021 (30) (1) 217-228; DOI: 10.1158/1055-9965.EPI-20-0739
Jump to section
Advertisement